# Opendoor Technologies Inc.: financial statements, quarterly OPEN · Nasdaq · CIK 1801169 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/open.md) · [Financials](/companies/open/financials.md) · [Filings](/companies/open/filings.md) · [Insiders](/companies/open/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/open/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [980](/filings/0001801169-24-000177.md) | [870 d](/filings/0001801169-26-000010.md) | [1,181](/filings/0001801169-25-000038.md) | [1,511](/filings/0001801169-25-000074.md) | [1,377](/filings/0001801169-25-000092.md) | [1,084 d](/filings/0001801169-26-000010.md) | [1,153](/filings/0001801169-26-000014.md) | [1,567](/filings/0001801169-26-000021.md) | [915](/filings/0001801169-25-000092.md) | [736 d](/filings/0001801169-26-000010.md) | [720](/filings/0001801169-26-000014.md) | [883](/filings/0001801169-26-000021.md) | | Cost of revenue | $m | [884](/filings/0001801169-24-000177.md) | [798 d](/filings/0001801169-26-000010.md) | [1,067](/filings/0001801169-25-000038.md) | [1,382](/filings/0001801169-25-000074.md) | [1,272](/filings/0001801169-25-000092.md) | [999 d](/filings/0001801169-26-000010.md) | [1,054](/filings/0001801169-26-000014.md) | [1,439](/filings/0001801169-26-000021.md) | [849](/filings/0001801169-25-000092.md) | [679 d](/filings/0001801169-26-000010.md) | [648](/filings/0001801169-26-000014.md) | [797](/filings/0001801169-26-000021.md) | | Gross profit | $m | [96.0](/filings/0001801169-24-000177.md) | [72.0 d](/filings/0001801169-26-000010.md) | [114](/filings/0001801169-25-000038.md) | [129](/filings/0001801169-25-000074.md) | [105](/filings/0001801169-25-000092.md) | [85.0 d](/filings/0001801169-26-000010.md) | [99.0](/filings/0001801169-26-000014.md) | [128](/filings/0001801169-26-000021.md) | [66.0](/filings/0001801169-25-000092.md) | [57.0 d](/filings/0001801169-26-000010.md) | [72.0](/filings/0001801169-26-000014.md) | [86.0](/filings/0001801169-26-000021.md) | | Research and development | $m | [42.0](/filings/0001801169-24-000177.md) | [46.0 d](/filings/0001801169-26-000010.md) | [41.0](/filings/0001801169-25-000038.md) | [37.0](/filings/0001801169-25-000074.md) | [30.0](/filings/0001801169-25-000092.md) | [33.0 d](/filings/0001801169-26-000010.md) | [21.0](/filings/0001801169-26-000014.md) | [21.0](/filings/0001801169-26-000021.md) | [19.0](/filings/0001801169-25-000092.md) | [18.0 d](/filings/0001801169-26-000010.md) | [24.0](/filings/0001801169-26-000014.md) | [27.0](/filings/0001801169-26-000021.md) | | Operating income | $m | [(79.0)](/filings/0001801169-24-000177.md) | [(115) d](/filings/0001801169-26-000010.md) | [(87.0)](/filings/0001801169-25-000038.md) | [(72.0)](/filings/0001801169-25-000074.md) | [(67.0)](/filings/0001801169-25-000092.md) | [(94.0) d](/filings/0001801169-26-000010.md) | [(56.0)](/filings/0001801169-26-000014.md) | [(13.0)](/filings/0001801169-26-000021.md) | [(68.0)](/filings/0001801169-25-000092.md) | [(150) d](/filings/0001801169-26-000010.md) | [(159)](/filings/0001801169-26-000014.md) | [(144)](/filings/0001801169-26-000021.md) | | Interest expense | $m | [47.0](/filings/0001801169-23-000138.md) | [37.0 d](/filings/0001801169-24-000016.md) | [37.0](/filings/0001801169-24-000085.md) | [30.0](/filings/0001801169-25-000074.md) | [34.0](/filings/0001801169-25-000092.md) | [32.0 d](/filings/0001801169-26-000010.md) | [33.0](/filings/0001801169-26-000014.md) | [36.0](/filings/0001801169-26-000021.md) | [34.0](/filings/0001801169-25-000092.md) | [28.0 d](/filings/0001801169-26-000010.md) | [23.0](/filings/0001801169-26-000014.md) | [29.0](/filings/0001801169-26-000021.md) | | Income tax | $m | [0.0](/filings/0001801169-24-000177.md) | [0.0 d](/filings/0001801169-26-000010.md) | [0.2](/filings/0001801169-25-000038.md) | [1.0](/filings/0001801169-25-000074.md) | [0.0](/filings/0001801169-25-000092.md) | [0.0 d](/filings/0001801169-26-000010.md) | [0.2](/filings/0001801169-26-000014.md) | [0.2](/filings/0001801169-26-000021.md) | [1.0](/filings/0001801169-25-000092.md) | [(1.0) d](/filings/0001801169-26-000010.md) | [0.1](/filings/0001801169-26-000014.md) | [0.1](/filings/0001801169-26-000021.md) | | Net income | $m | [(106)](/filings/0001801169-24-000177.md) | [(91.0) d](/filings/0001801169-26-000010.md) | [(109)](/filings/0001801169-25-000038.md) | [(92.0)](/filings/0001801169-25-000074.md) | [(78.0)](/filings/0001801169-25-000092.md) | [(113) d](/filings/0001801169-26-000010.md) | [(85.0)](/filings/0001801169-26-000014.md) | [(29.0)](/filings/0001801169-26-000021.md) | [(90.0)](/filings/0001801169-25-000092.md) | [(1,096) d](/filings/0001801169-26-000010.md) | [(173)](/filings/0001801169-26-000014.md) | [(162)](/filings/0001801169-26-000021.md) | | Diluted EPS | $ per share | [(0.16)](/filings/0001801169-24-000177.md) | not reported | [(0.16)](/filings/0001801169-25-000038.md) | [(0.13)](/filings/0001801169-25-000074.md) | [(0.11)](/filings/0001801169-25-000092.md) | not reported | [(0.12)](/filings/0001801169-26-000014.md) | [(0.04)](/filings/0001801169-26-000021.md) | [(0.12)](/filings/0001801169-25-000092.md) | not reported | [(0.18)](/filings/0001801169-26-000014.md) | [(0.17)](/filings/0001801169-26-000021.md) | | Basic EPS | $ per share | [(0.16)](/filings/0001801169-24-000177.md) | not reported | [(0.16)](/filings/0001801169-25-000038.md) | [(0.13)](/filings/0001801169-25-000074.md) | [(0.11)](/filings/0001801169-25-000092.md) | not reported | [(0.12)](/filings/0001801169-26-000014.md) | [(0.04)](/filings/0001801169-26-000021.md) | [(0.12)](/filings/0001801169-25-000092.md) | not reported | [(0.18)](/filings/0001801169-26-000014.md) | [(0.17)](/filings/0001801169-26-000021.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfRevenue - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [1,154](/filings/0001801169-24-000177.md) | [999](/filings/0001801169-26-000010.md) | [953](/filings/0001801169-25-000038.md) | [790](/filings/0001801169-25-000074.md) | [829](/filings/0001801169-25-000092.md) | [671](/filings/0001801169-26-000010.md) | [559](/filings/0001801169-26-000014.md) | [789](/filings/0001801169-26-000021.md) | [962](/filings/0001801169-25-000092.md) | [962](/filings/0001801169-26-000021.md) | [999](/filings/0001801169-26-000014.md) | [896](/filings/0001801169-26-000021.md) | | Current assets | $m | [3,819](/filings/0001801169-23-000138.md) | [3,445](/filings/0001801169-25-000017.md) | [3,284](/filings/0001801169-24-000085.md) | [3,249](/filings/0001801169-24-000139.md) | [3,263](/filings/0001801169-24-000177.md) | [2,997](/filings/0001801169-26-000010.md) | [3,152](/filings/0001801169-25-000038.md) | [2,797](/filings/0001801169-25-000074.md) | [2,587](/filings/0001801169-25-000092.md) | [2,299](/filings/0001801169-26-000021.md) | [2,242](/filings/0001801169-26-000014.md) | [2,850](/filings/0001801169-26-000021.md) | | Total assets | $m | [3,947](/filings/0001801169-23-000138.md) | [3,567](/filings/0001801169-25-000017.md) | [3,404](/filings/0001801169-24-000085.md) | [3,372](/filings/0001801169-24-000139.md) | [3,411](/filings/0001801169-24-000177.md) | [3,126](/filings/0001801169-26-000010.md) | [3,277](/filings/0001801169-25-000038.md) | [2,907](/filings/0001801169-25-000074.md) | [2,700](/filings/0001801169-25-000092.md) | [2,407](/filings/0001801169-26-000021.md) | [2,349](/filings/0001801169-26-000014.md) | [2,961](/filings/0001801169-26-000021.md) | | Current liabilities | $m | [74.0](/filings/0001801169-23-000138.md) | [70.0](/filings/0001801169-25-000017.md) | [74.0](/filings/0001801169-24-000085.md) | [393](/filings/0001801169-24-000139.md) | [721](/filings/0001801169-24-000177.md) | [529](/filings/0001801169-26-000010.md) | [1,053](/filings/0001801169-25-000038.md) | [643](/filings/0001801169-25-000074.md) | [914](/filings/0001801169-25-000092.md) | [327](/filings/0001801169-26-000021.md) | [317](/filings/0001801169-26-000014.md) | [968](/filings/0001801169-26-000021.md) | | Total liabilities | $m | [2,927](/filings/0001801169-23-000138.md) | [2,600](/filings/0001801169-25-000017.md) | [2,505](/filings/0001801169-24-000085.md) | [2,527](/filings/0001801169-24-000139.md) | [2,610](/filings/0001801169-24-000177.md) | [2,413](/filings/0001801169-26-000010.md) | [2,632](/filings/0001801169-25-000038.md) | [2,276](/filings/0001801169-25-000074.md) | [1,889](/filings/0001801169-25-000092.md) | [1,402](/filings/0001801169-26-000021.md) | [1,395](/filings/0001801169-26-000014.md) | [2,047](/filings/0001801169-26-000021.md) | | Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [1,020](/filings/0001801169-24-000177.md) | [967](/filings/0001801169-26-000010.md) | [899](/filings/0001801169-25-000074.md) | [845](/filings/0001801169-25-000092.md) | [801](/filings/0001801169-25-000092.md) | [713](/filings/0001801169-26-000021.md) | [645](/filings/0001801169-26-000021.md) | [631](/filings/0001801169-26-000021.md) | [811](/filings/0001801169-25-000092.md) | [1,005](/filings/0001801169-26-000021.md) | [954](/filings/0001801169-26-000021.md) | [914](/filings/0001801169-26-000021.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: not reported - Current portion of debt: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [(216) d](/filings/0001801169-24-000177.md) | [(542) d](/filings/0001801169-26-000010.md) | [(178)](/filings/0001801169-25-000038.md) | [(399) d](/filings/0001801169-25-000074.md) | [62.0 d](/filings/0001801169-25-000092.md) | [(80.0) d](/filings/0001801169-26-000010.md) | [(279)](/filings/0001801169-26-000014.md) | [823 d](/filings/0001801169-26-000021.md) | [435 d](/filings/0001801169-25-000092.md) | [70.0 d](/filings/0001801169-26-000010.md) | [(246)](/filings/0001801169-26-000014.md) | [(718) d](/filings/0001801169-26-000021.md) | | Capital expenditure | $m | [11.0 d](/filings/0001801169-24-000177.md) | [9.0 d](/filings/0001801169-26-000010.md) | [8.0](/filings/0001801169-25-000038.md) | [8.0 d](/filings/0001801169-25-000074.md) | [6.0 d](/filings/0001801169-25-000092.md) | [3.0 d](/filings/0001801169-26-000010.md) | [4.0](/filings/0001801169-26-000014.md) | [2.0 d](/filings/0001801169-26-000021.md) | [3.0 d](/filings/0001801169-25-000092.md) | [3.0 d](/filings/0001801169-26-000010.md) | [4.0](/filings/0001801169-26-000014.md) | [5.0 d](/filings/0001801169-26-000021.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [630](/filings/0001801169-23-000138.md) | [642](/filings/0001801169-24-000085.md) | [667](/filings/0001801169-24-000139.md) | [662](/filings/0001801169-24-000177.md) | [682](/filings/0001801169-25-000038.md) | [693](/filings/0001801169-25-000074.md) | [705](/filings/0001801169-25-000092.md) | [724](/filings/0001801169-26-000014.md) | [729](/filings/0001801169-26-000021.md) | [742](/filings/0001801169-25-000092.md) | [959](/filings/0001801169-26-000014.md) | [966](/filings/0001801169-26-000021.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 971,091,050 at 2026-07-28, from the cover of the [10-Q filed 2026-08-04](/filings/0001801169-26-000021.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.